Explore / Peer-reviewed article
Peer-reviewed articleOpen access

The dose-dependent efficacy of esketamine in spinal surgery with intraoperative neuroelectrophysiological monitoring: a randomized controlled trial.

Lin C, Wang J, Zhang L, Yuan L, Liu G, Zhu M, Zhang L

Frontiers in medicineJun 18, 2025License: open accessChina0 citationsDOI: 10.3389/fmed.2025.1579908

Abstract

<h4>Purpose</h4>This study aims to validate the efficacy and safety of combining different doses of esketamine with propofol, remifentanil, and dexmedetomidine in spinal surgery under intra-operative neuroelectrophysiological monitoring (IONM).<h4>Methods</h4>All enrolled patients underwent a total intravenous anesthesia (TIVA) maintenance regimen, which included propofol, remifentanil, and dexmedetomidine. The patients were randomly assigned to four groups based on the use and dosage of esketamine: Group Control (TIVA + NS), Group A (TIVA + Esketamine 0.1 mg/kg/h), Group B (TIVA + Esketamine 0.3 mg/kg/h), and Group C (TIVA + Esketamine 0.5 mg/kg/h). The study measured vital signs, consumption of anesthetics, operation time, blood loss, awakening time in the postanesthesia care unit (PACU), visual analog scale (VAS) pain score, quality of recovery (QoR) -15 score, and dosage of supplementary analgesics. Additionally, adverse postoperative reactions were recorded.<h4>Results</h4>Group B had lower dosages of propofol (<i>P</i> = 0.021), remifentanil (<i>P</i> = 0.001), and dexmedetomidine (<i>P</i> < 0.001) than the Control Group, while Group C had lower dosages of remifentanil and dexmedetomidine (<i>P</i> < 0.001) than the Control Group. The postoperative mean arterial pressure (MAP) was lower in Group B than in the Control Group (<i>P</i> = 0.028). Patients in Group C experienced a prolonged awakening time (<i>P</i> < 0.001) but had lower VAS pain scores at PACU than those in the Control group (<i>P</i> = 0.044). Both QoR-15 scores and MoCA scores were significantly higher for patients in Groups A, B, and C compared to those of the Control group (QoR-15: <i>P</i> = 0.001, < 0.001, < 0.001; MoCA: <i>P</i> = 0.004, < 0.001, < 0.001). Group B had few postoperative complications.<h4>Conclusion</h4>The dose of 0.3 mg/kg/h esketamine is safe and effective for spinal surgery with IONM, improving control of postoperative complications.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePain

Keywords

DoseSpinal Surgeryclinical efficacyEsketamineIntraoperative Neuroelectrophysiological Monitoring

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.